BioIVT Profile Banner
BioIVT Profile
BioIVT

@BioIVT

Followers
285
Following
81
Media
2K
Statuses
2K

Your partner in ELEVATING SCIENCE.

USA
Joined July 2014
Don't wanna be here? Send us removal request.
@BioIVT
BioIVT
2 days
We’re proud to deliver personalized #biospecimens & research services to #lifescience & #diagnostics organizations that are enhancing and extending lives through medical breakthroughs: #ELEVATINGscience #Biospecimens #SmarterScience
0
0
0
@BioIVT
BioIVT
3 days
Subcellular fractions offer an efficient and cost-effective alternative to whole-cell systems. But with so many options, how do you know which best fits your needs? Download our guide on choosing the right test systems for your #ADME studies:
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
1
@BioIVT
BioIVT
4 days
Just because two #biospecimens seem the same, it doesn’t mean they are. Lack of quality #biospecimens resulted in 60% of researchers questioning their findings and 81% limiting the scope of their work.* How can you avoid these issues? Learn more:
Tweet media one
0
0
1
@BioIVT
BioIVT
5 days
Jordan Hunter, PhD shares insights on manufacturing hurdles for the #CellandGeneTherapy / #ATMP industry in a roundtable with Pharma's Almanac, discussing scalability, supply chain fragility, and how to overcome these obstacles:
Tweet media one
0
0
0
@BioIVT
BioIVT
6 days
Understanding non-CYP metabolism requires a strategic, structure-informed approach. From #hepatocytes to recombinant #enzymes, knowing when to go broad — and when to go deep — can make or break your study. Dive into practical insights from Dr. Ogilvie:
Tweet media one
0
0
1
@BioIVT
BioIVT
9 days
#Science & #art both begin with a bold stroke. In honor of World Watercolor Month, we’re celebrating the beauty of exploration through both brush and bench with this #ScienceArt piece inspired by #Okeeffe. Get it (and others) here:
Tweet media one
0
0
1
@BioIVT
BioIVT
9 days
Choosing the right cellular starting and raw materials vendor for your #CellandGeneTherapy is crucial. Discover three key strategies to evaluate and find the perfect fit. ➡️ #CellTherapy #GeneTherapy #AdvancedTherapies #QualityControl #VendorSelection
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
0
@BioIVT
BioIVT
10 days
A recent customer study using human #glioblastoma tissue provided insights into the role of disulfidptosis in glioma progression and its potential as a therapeutic target: #GlioblastomaAwareness #GlioblastomaAwarenessDay
Tweet media one
0
0
1
@BioIVT
BioIVT
11 days
Our presentation from last month’s forum on the business & science of #exosomes by John Ludlow, PhD, Sr. Scientific Advisor for Exosomes at BioIVT, is now available online!
Tweet media one
0
0
0
@BioIVT
BioIVT
12 days
Disease is always deeply personal, affecting all of us at some point in life. This reality drives our mission to support researchers worldwide in advancing #PersonalizedMedicine, ensuring they have the highest quality biospecimens and data. #ItsPersonal #WhyWeDoWhatWeDo
Tweet media one
Tweet media two
Tweet media three
0
0
1
@BioIVT
BioIVT
13 days
Did you know that BioIVT offers the same transporter vesicles that we use in our own vesicle assays? The vesicles, manufactured by GenoMembrane, are particularly ideal for studying efflux (ABC) #drugtransporters:
Tweet media one
0
0
1
@BioIVT
BioIVT
16 days
Please join us in welcoming Kent Grindstaff, PhD as our new Consulting Director. We are excited to have him on board and look forward to the valuable contributions he will make to our team! Learn more about Kent’s experience:
Tweet media one
0
0
1
@BioIVT
BioIVT
16 days
Several of the presentations from our #neuroscience symposium in South San Francisco last week are now available online! Access the recordings and slides: #NeuroscienceResearch #Biomarkers #DrugDevelopment #BioIVTNeuroExcellence
Tweet media one
0
0
1
@BioIVT
BioIVT
17 days
#Liquidbiopsy is reshaping precision medicine, extracting genetic, proteomic, and epigenetic data from blood, urine, and potentially other biofluids such as saliva, cerebrospinal fluid, sweat, and even tears. Learn more:
Tweet media one
0
0
0
@BioIVT
BioIVT
18 days
As we discuss the FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies (, we thought we would highlight a recent publication about a novel milli-fluidic human liver tissue chip (LTC) designed by @JavelinBiotech:
Tweet media one
0
0
1
@BioIVT
BioIVT
18 days
The FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies outlines a 3–5 year action plan to make animal studies the exception rather than the rule. Learn more about the roadmap and our ability to support New Approach Methodologies (NAMs):
Tweet media one
0
0
2
@BioIVT
BioIVT
19 days
While trends come and go, access to research-quality #biospecimens should never be out of reach. That’s why BioIVT is bringing back 2015 pricing on our #ASTERAND® high-quality, ethically sourced, disease-state tissue:
Tweet media one
0
0
0
@BioIVT
BioIVT
19 days
A new #grant program with the goal of reducing adverse drug interactions allows researchers to apply for free lots of cryosuspension #hepatocytes that have been selected and characterized for non-CYP metabolism research. Learn more and submit a proposal:
Tweet media one
0
0
1
@BioIVT
BioIVT
20 days
Download our #ScientificPoster: “Impact of Donor Demographics and Mobilization Regimens on WBC and CD34+ Cell Yields”: #HSPCs #StemCells #ProgenitorCells #CellTherapy #GeneTherapy
Tweet media one
0
0
0
@BioIVT
BioIVT
20 days
BioIVT’s #Visionaire addresses #AI challenges in reproducibility, scalability & regulatory compliance with decades of clinically curated, comprehensive biospecimen data collected under strict regulatory & privacy standards: #oncology #neurodegenerative
Tweet media one
0
0
1